Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENGRAFT: Ecosystem Nourishment for Gut Restoration After Fecal Transplantation
NCT07826793Phase 2Not yet recruiting
- Sponsor
- Stanford University
- Start
- Dec 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fecal microbiota transplant capsules in aging (4 arms), sponsored by Stanford University. Primary endpoint: Difference in DunedinPACE at 8 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
fecal microbiota transplant capsules
03
Conditions
aging
Beyond the preview
Go deeper on NCT07826793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826793.